Parenteral injection system
US-2024165333-A1 · May 23, 2024 · US
US12427241B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12427241-B2 |
| Application number | US-202017770326-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2020 |
| Priority date | Oct 24, 2019 |
| Publication date | Sep 30, 2025 |
| Grant date | Sep 30, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A drug delivery system includes a packaging housing a first component including at least one of a drug product, a diluent, a saline solution, or an IV stabilizing solution (“IVSS”) and a second component comprising at least one of the drug product, the diluent, the saline solution, and the IVSS, the first component being different than the second component. The first component is disposed in a first container in a storage state and the first container is positioned in a first compartment of the packaging housing. The second component is disposed in a second container in a storage state and the second container is positioned in a second compartment of the packaging housing. At least one of the first compartment and the second compartment may include an individual seal and wherein each of the individual seals and the first and second compartments are sterilized.
Opening claim text (preview).
What is claimed is: 1. A drug delivery system comprising: a packaging housing; a first component including at least one of a drug product, a diluent, a saline solution, or an IV stabilizing solution (“IVSS”), wherein the first component is disposed in a first container in a storage state and the first container is positioned in a first compartment of the packaging housing; a second component including at least one of the drug product, the diluent, the saline solution, or the IVSS, wherein the first component is different than the second component and the second component is disposed in a second container in a storage state and the second container is positioned in a second compartment of the packaging housing; wherein each of the first compartment and the second compartment includes an individual seal; and a third component including at least one of the drug product, the diluent, the saline solution, and the IVSS, wherein the third component is different than the first component and the second component, wherein the third component is disposed in a third container in a storage state and the third container is positioned in a third compartment of the packaging housing, wherein the packaging housing defines a housing bottom surface at least one of the first, second, and third compartments has a compartment bottom surface that is non-parallel to the housing bottom surface to facilitate removal of air bubbles. 2. The drug delivery system as in claim 1 , wherein at least one of the first, second, and third containers comprises an IV bag, and wherein the packaging housing includes at least one port holder configured to secure at least one port of the IV bag in a storage position, and wherein the port holder is removable from the packaging housing to facilitate removal of the IV bag from the packaging housing. 3. The drug delivery system as in claim 1 , wherein the packaging housing includes a stand for supporting instructions for use. 4. The drug delivery system as in claim 1 , wherein the drug product delivery is packaged as a kit. 5. The drug delivery system as in claim 4 , wherein the kit further includes a second packaging housing, wherein at least one of the first and second packaging housing is configured to be maintained under refrigerated conditions and the other of the first and second packaging housing is configured to be maintained at about room temperature.
Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor · CPC title
Containers having several compartments for products to be mixed · CPC title
Bag-type containers · CPC title
delivered via infusion or injection · CPC title
having peelable seals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.